Skip to main content
logo
Artgen Biotech PJSC (MOEX:ISKJ)
Russia flag Russia · Delayed Price · Currency is RUB
59.54
+0.84 (1.43%)
At close: Jul 8, 2022

Artgen Biotech PJSC Financials Overview

Millions RUB. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,7561,7161,5211,3691,1371,181
Revenue Growth
2.35%12.80%11.18%20.38%-3.72%8.93%
Gross Profit
1,1441,1041,082974.09670.34719.4
Operating Income
96.66131.9299.62275.3697.46130.42
Net Income
-10.896.95214.91168.8646.1211.63
Earnings Per Share
-1.292.891.820.530.15
EPS Growth
--55.36%58.79%243.40%264.54%-85.01%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
752.18730.49538.46572.33227.06193.8
Total Debt
1,004964.99737.65786.96831.6617.13
Net Cash (Debt)
-251.6-234.5-199.2-214.62-604.55-423.33
Net Cash Growth
------
Net Cash Per Share
--3.12-2.68-2.32-6.96-5.29

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-190.75481.83434.85220.3280.8
Capital Expenditures
--170.39-99.68-204.29-135.93-153.3
Free Cash Flow
-20.36382.16230.5684.37127.51
Free Cash Flow Growth
--94.67%65.75%173.26%-33.83%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.16%64.34%71.13%71.18%58.96%60.92%
Operating Margin
5.50%7.69%19.69%20.12%8.57%11.04%
Pretax Margin
-1.75%4.98%14.29%15.45%2.58%2.49%
Profit Margin
-0.61%5.65%14.12%12.34%4.06%0.98%
FCF Margin
-1.19%25.12%16.85%7.42%10.80%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
8133.80-20.4826.1792.95711.21
P/FCF Ratio
44.26-11.5219.1750.8064.88
PS Ratio
2.44-2.893.233.777.01